News Releases Year: All News2020201920182017201620152014201320122011 Items per page All News2550 February 12, 2020 Summary ToggleAllena Pharmaceuticals Announces Streamlined Design for URIROX-2, Second Pivotal Clinical Trial of Reloxaliase for Enteric Hyperoxaluria Read more December 4, 2019 Summary ToggleAllena Pharmaceuticals Provides Updates on Reloxaliase Development Program and Corporate Activities Read more November 25, 2019 Summary ToggleAllena Pharmaceuticals to Present at Evercore ISI 2nd Annual HEALTHCONx Conference Read more November 13, 2019 Summary ToggleAllena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update Read more November 7, 2019 Summary ToggleAllena Pharmaceuticals Reports Positive Reloxaliase Topline Results from URIROX-1 Trial and from Study 206 Read more October 17, 2019 Summary ToggleAllena Pharmaceuticals to Present New Data on Reloxaliase and ALLN-346 Development Programs at Upcoming ASN Kidney Week and ACR/ARP Annual Meeting Read more September 16, 2019 Summary ToggleAllena Pharmaceuticals Completes Enrollment in Pivotal Phase 3 URIROX-1 Trial Evaluating Reloxaliase in Patients with Enteric Hyperoxaluria Read more September 11, 2019 Summary ToggleAllena Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Enteric Hyperoxaluria and Potential for Reloxaliase Read more August 29, 2019 Summary ToggleAllena Pharmaceuticals to Participate in Upcoming Investor Conferences in September Read more August 7, 2019 Summary ToggleAllena Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update Read more Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
